Cargando…
Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
Objective: The objective of this study was to examine whether plasma transferrin levels are associated with longitudinal changes in cognitive performance in older individuals with normal cognition (CN), mild cognitive impairment (MCI), and mild Alzheimer’s disease (AD). Methods: At baseline, there w...
Autores principales: | Guan, Jingjing, Wang, Peng, Lu, Liping, Zhao, Guanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080847/ https://www.ncbi.nlm.nih.gov/pubmed/32226377 http://dx.doi.org/10.3389/fnagi.2020.00038 |
Ejemplares similares
-
Aspirin using was associated with slower cognitive decline in patients with Alzheimer’s disease
por: Weng, Jinyan, et al.
Publicado: (2021) -
Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases
por: Mariani, S., et al.
Publicado: (2013) -
Functional Connectivity Changes Across the Spectrum of Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Wang, Ziqi, et al.
Publicado: (2019) -
Divergent Connectivity Changes in Gray Matter Structural Covariance Networks in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer’s Disease
por: Fu, Zhenrong, et al.
Publicado: (2021) -
Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
por: Langhough Koscik, Rebecca, et al.
Publicado: (2021)